CTI Announces Additional College Of American Pathologists (CAP) Laboratory Accreditation

CTI Clinical Trials and Consulting, a full-service global research provider, is thrilled to announce that our North American laboratory facility has been granted the prestigious College of American Pathologists (CAP) Accreditation for Safety Testing. This esteemed recognition is awarded to laboratories that demonstrate adherence to the most rigorous standards, highlighting CTI's commitment to excellence in quality and precision across all aspects of our laboratory services.

“We are delighted that CTI Laboratories has received another CAP Accreditation,” said Alison Woodworth, PhD, DABCC, Clinical Director, Global Laboratory Services. “This accreditation demonstrates our commitment to patient safety and the highest quality clinical laboratory testing. CTI’s global central laboratories provide industry leading service in both the clinical trial and medical research communities.”

The CAP Laboratory Accreditation Program is acknowledged by the U.S. Federal Government as being on par with or even stricter than the government's inspection standards, making it the premier benchmark for clinical laboratory accreditation. This rigorous accreditation process emphasizes excellence in pathology and laboratory medicine through adherence to regulatory standards and routine demonstration of accurate test results. After months of preparation, CAP conducts a thorough site visit and detailed review of the laboratory’s documentation and quality management systems. Additionally, CAP inspectors evaluate the qualifications of the laboratory personnel, the maintenance of the instrumentation and facilities, the safety program and its records, as well as the general administration.

CTI offers a worldwide, full-service laboratory, specializing in a customized services including kit building, logistics, sample management and processing (including PBMC processing), bioanalytical and central safety testing, and sample storage through our biorepository. Our extensive and accomplished history spans across method development, validation, and the quantitative analysis of both small molecules and biologics. CTI’s expertise covers the entire spectrum of drug development in numerous clinical specialties, ranging from early preclinical stages through all clinical development phases, including bioequivalence.